Based on seven years of research, Brooks Running is launching the all new Levitate with DNA AMP – billed as a shoe engineered to provide the most energy return of leading performance running shoes. The springy and responsive Brooks Levitate is now available for pre-order and will be available worldwide from 30 September.
“We’re pushing the limits of energy return with the new Brooks Levitate and are excited to unveil a shoe that has been engineered from the ground up to provide runners with an infinitely energetic experience,” said Carson Caprara, Director of Global Product Line Management at Brooks Running.
“The Brooks Levitate features our revolutionary new DNA AMP midsole technology that releases energy straight back to the runner, making the experience so fun they might feel like running forever.”
The Brooks Levitate is the first shoe to feature the company’s exclusive DNA AMP midsole. Created in partnership with BASF – DNA AMP is a brand new polyurethane (PU)-based cushioning system engineered to provide energy return. The foundation of DNA AMP is a PU foam that naturally expands, returning energy as force is applied.
To deliver an amplified experience, Brooks encased the foam in a thermoplastic polyurethane (TPU) skin that resists horizontal expansion to deliver energy directly back to the runner. The result is an engineered compound that provides energy return as well as an eye-catching chrome-like finish that ‘feels as great underfoot as it looks’.
To add to the energizing experience of the shoe, the Brooks Levitate features an integrated Fit Knit upper that aims to comfortably accommodate a runner’s foot as it moves and expands. Brooks Fit Knit utilizes a circular knit process to create an engineered upper that provides breathability where desired and structure where needed.
A flexible, arrow-point pattern on the outsole of the shoe helps runners move quickly from heel to toe, without losing energy. The Brooks Levitate with DNA AMP will be available for US$150 in two colours for women and two colours for men.